Selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis B virus-infected patients

BACKGROUND: This study aimed to investigate the association between the use of selective serotonin reuptake inhibitors (SSRIs) and the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection. METHODS: We conducted a population-based cohort study by using cla...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chia-Ming, Hsieh, Ming-Shun, Yang, Tsung-Chieh, Hsieh, Vivian Chia-Rong, Chiang, Jen-Huai, Huang, Hsien-Hao, How, Chorng-Kuang, Hu, Sung-Yuan, Yen, David Hung-Tsang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713708/
https://www.ncbi.nlm.nih.gov/pubmed/29238221
http://dx.doi.org/10.2147/CMAR.S148097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713708/
https://www.ncbi.nlm.nih.gov/pubmed/29238221
http://dx.doi.org/10.2147/CMAR.S148097

Ejemplares similares